ReviewThe review of diabetic studies : RDS2012

In vivo delivery of nucleic acid-formulated microparticles as a potential tolerogenic vaccine for type 1 diabetes.

Valentina Di Caro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.